Mark Taylor

Phosphorylated α‐synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease

Penelope G. Foulds, John Mitchell, Angela Parker et al. · The FASEB Journal · 2011 · 202 citations

Development of a Proteolytically Stable Retro-Inverso Peptide Inhibitor of β-Amyloid Oligomerization as a Potential Novel Treatment for Alzheimer’s Disease

Mark Taylor, Susan A. Moore, Jennifer Mayes et al. · Biochemistry · 2010 · 155 citations

Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptide

Mark Taylor, Susan A. Moore, Spyridon Mourtas et al. · Nanomedicine Nanotechnology Biology and Medicine · 2011 · 145 citations

Nanoparticles, Nanomedicine, Lipid Ligand-functionalized Nanoliposomes +10

Plasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration

Penelope G. Foulds, Yvonne S. Davidson, Manjari Mishra et al. · Acta Neuropathologica · 2009 · 93 citations · Full text

Frontotemporal Lobar Degeneration, Neurodegenerative Diseases, Corticobasal Degeneration +11

A Novel Retro-Inverso Peptide Inhibitor Reduces Amyloid Deposition, Oxidation and Inflammation and Stimulates Neurogenesis in the APPswe/PS1ΔE9 Mouse Model of Alzheimer’s Disease

Vadivel Parthsarathy, Paula L. McClean, Christian Hölscher et al. · PLoS ONE · 2013 · 89 citations · Full text